BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10673767)

  • 1. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
    Lee D; Huang W; Lim AT
    Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 receptors mediate dopamine stimulation of immunoreactive atrial natriuretic factor (ANF) release and pro-ANF messenger ribonucleic acid expression of rat hypothalamic neurons in culture.
    Lee D; Huang W; Lim AT
    Endocrinology; 1995 Feb; 136(2):591-7. PubMed ID: 7835293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
    Coronas V; Krantic S; Jourdan F; Moyse E
    Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D5 dopamine receptors mediate estrogen-induced stimulation of hypothalamic atrial natriuretic factor neurons.
    Lee D; Dong P; Copolov D; Lim AT
    Mol Endocrinol; 1999 Feb; 13(2):344-52. PubMed ID: 9973263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
    Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
    PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
    Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
    Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
    Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells.
    Sakolsky DJ; Ashby B
    Brain Res Mol Brain Res; 2000 Dec; 84(1-2):158-61. PubMed ID: 11113544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
    Kozell LB; Machida CA; Neve RL; Neve KA
    J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids inhibit D1B, but not D2, receptor-mediated effects on hypothalamic atrial natriuretic factor neurons.
    Lee D; Huang W; Copolov DL; Lim AT
    Endocrinology; 1995 Dec; 136(12):5570-6. PubMed ID: 7588310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
    Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
    PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hormonally induced inositol trisphosphate production in Transfected GH4C1 cells: A novel role for the D5 subtype of the dopamine receptor.
    White BH; Kimura K; Sidhu A
    Neuroendocrinology; 1999 Mar; 69(3):209-16. PubMed ID: 10087453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen.
    Lee D; Wang L; Dong P; Tran T; Copolov D; Lim AT
    Mol Psychiatry; 2001 Jan; 6(1):112-7. PubMed ID: 11244496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
    Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
    J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 receptors mediate dopamine suppression of irANF release and pro-ANF mRNA expression of rat hypothalamic neurons in culture.
    Lee D; Huang W; Copolov DL; Lim AT
    Mol Cell Neurosci; 1994 Dec; 5(6):523-9. PubMed ID: 7704425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus.
    Rossato JI; Radiske A; Kohler CA; Gonzalez C; Bevilaqua LR; Medina JH; Cammarota M
    Neurobiol Learn Mem; 2013 Nov; 106():66-70. PubMed ID: 23891712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
    Sidhu A; Olde B; Humblot N; Kimura K; Gardner N
    Neuroscience; 1999; 91(2):537-47. PubMed ID: 10366011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase.
    Harrison LM; He Y
    J Neurosci Res; 2011 Jun; 89(6):874-82. PubMed ID: 21374700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.
    Wong AC; Shetreat ME; Clarke JO; Rayport S
    Neuroscience; 1999 Mar; 89(1):221-33. PubMed ID: 10051231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.